Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

754 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Magi-Galluzzi C, et al. Among authors: kaplan i. Lab Invest. 1997 Jan;76(1):37-51. Lab Invest. 1997. PMID: 9010448
Radiotherapy for prostatic cancer: patient selection and the impact of local control.
Kaplan ID, Cox RS, Bagshaw MA. Kaplan ID, et al. Urology. 1994 May;43(5):634-9. doi: 10.1016/0090-4295(94)90177-5. Urology. 1994. PMID: 8165765
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. D'Amico AV, et al. Among authors: kaplan i. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):335-40. doi: 10.1016/s0360-3016(97)00320-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308936
Minimizing rectal and urinary complications in prostate brachytherapy.
Kaplan I. Kaplan I. J Endourol. 2000 May;14(4):381-3. doi: 10.1089/end.2000.14.381. J Endourol. 2000. PMID: 10910156
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. McMenamin ME, et al. Among authors: kaplan i. Cancer Res. 1999 Sep 1;59(17):4291-6. Cancer Res. 1999. PMID: 10485474
Heterogeneity of androgen receptor content in advanced prostate cancer.
Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. Magi-Galluzzi C, et al. Among authors: kaplan i. Mod Pathol. 1997 Aug;10(8):839-45. Mod Pathol. 1997. PMID: 9267828
Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate.
Brufsky A, Fontaine-Rothe P, Berlane K, Rieker P, Jiroutek M, Kaplan I, Kaufman D, Kantoff P. Brufsky A, et al. Among authors: kaplan i. Urology. 1997 Jun;49(6):913-20. doi: 10.1016/s0090-4295(97)00091-5. Urology. 1997. PMID: 9187700 Clinical Trial.
Her-2-neu expression and progression toward androgen independence in human prostate cancer.
Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. Among authors: kaplan i. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683
Detection of circulating tumor cells in men with localized prostate cancer.
Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. Among authors: kaplan i. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455
Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume.
Petit JH, Gluck C, Kiger WS 3rd, Laury Henry D, Karasiewicz C, Talcott JA, Berg S, Holupka EJ, Kaplan ID. Petit JH, et al. Brachytherapy. 2007 Oct-Dec;6(4):267-71. doi: 10.1016/j.brachy.2007.08.007. Epub 2007 Oct 23. Brachytherapy. 2007. PMID: 17959423
754 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback